SCHEMBL23099885

SCHEMBL23099885

Cc1cc(OCc2ccccc2)c(C(F)(F)F)c(F)c1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.49
▸ TDP1 Q9NUW8 2/20 0.49
▸ L3MBTL1 Q9Y468 2/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ MAPK14 Q16539 2/20 0.44
▸ MRGPRX4 Q96LA9 3/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ STAT3 P40763 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ KDM1A O60341 2/20 0.40
▸ FFAR4 Q5NUL3 2/20 0.40
▸ HTR2C P28335 1/20 0.39
▸ SLC6A4 P31645 1/20 0.39
▸ HTR2B P41595 1/20 0.39
▸ MCL1 Q07820 1/20 0.39
▸ LIPE Q05469 1/20 0.39
▸ PTPN2 P17706 1/20 0.39
▸ PTPN1 P18031 1/20 0.39
▸ PTPN6 P29350 1/20 0.39
▸ PTGER1 P34995 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26360003 0.83 L3MBTL1 (0.56) MAPTTDP1L3MBTL1MAPK1MAPK14
SCHEMBL23099883 0.75 LOX (0.34) AOC3
SCHEMBL27438960 0.74 HTT (0.50) MAPTTDP1L3MBTL1MAPK1MAPK14
SCHEMBL25081934 0.74 MAPT (0.64) MAPTTDP1L3MBTL1MAPK1MAPK14
SCHEMBL8761479 0.74 MAPT (0.51) MAPTTDP1L3MBTL1MAPK1MAPK14
SCHEMBL8755664 0.74 MAPT (0.51) MAPTTDP1L3MBTL1MAPK1MAPK14
SCHEMBL20607341 0.74 MAPK14 (0.45) MAPTTDP1L3MBTL1MAPK1MAPK14
SCHEMBL29628710 0.74 MAPK14 (0.45) MAPTTDP1L3MBTL1MAPK1MAPK14
SCHEMBL23099870 0.73 TUBB1 (0.38) MAPK1HTTHTR2C
SCHEMBL2892314 0.73 MAPT (0.58) MAPTTDP1L3MBTL1MAPK1MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303495-A9 PYRIDINE OXYNITRIDE, PREPARATION METHOD THEREFOR AND USE THEREOF SHANGHAI JEYOU PHARMACEUTICAL CO., LTD. (CN) 2023-09-28 — — US disclosed
US-20230026907-A1 PYRIDINE OXYNITRIDE, PREPARATION METHOD THEREFOR AND USE THEREOF ORION CORP (FI) 2023-01-26 — — US disclosed
WO-2021047622-A1 PYRIDINE OXYNITRIDE, PREPARATION METHOD THEREFOR AND USE THEREOF 上海济煜医药科技有限公司 2021-03-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026907-A1 PYRIDINE OXYNITRIDE, PREPARATION METHOD THEREFOR AND USE THEREOF SCN11A, HCN4, CACNA1F MAPT 717/4885TDP1 2297/4885L3MBTL1 4591/4885
US-20230303495-A9 PYRIDINE OXYNITRIDE, PREPARATION METHOD THEREFOR AND USE THEREOF SCN11A, HCN4, CACNA1F MAPT 717/4885TDP1 2297/4885L3MBTL1 4591/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback